New Mechanistic Insights of Melasma

References

• Sarkar R, Gokhale N, Godse K, et al. Medical management of melasma: a review with consensus recommendations by Indian pigmentary expert group. Indian J Dermatol. 2017;62(6):558–577. doi:10.4103/ijd.IJD_489_17
   PubMed Web of Science ®Google Scholar
• Sarkar R, Jagadeesan S, Basavapura Madegowda S, et al. Clinical and epidemiologic features of melasma: a multicentric cross-sectional study from India. Int J Dermatol. 2019;58(11):1305–1310. doi:10.1111/ijd.14541
   PubMed Web of Science ®Google Scholar
• Espósito MCC, Espósito ACC, Jorge MFS, et al. Depression, anxiety, and self‐esteem in women with facial melasma: an Internet‐based survey in Brazil. Int J Dermatol. 2021;60(9):e346–e347. doi:10.1111/ijd.15490
   PubMed Web of Science ®Google Scholar
• Harumi O, Goh CL. The effect of melasma on the quality of life in a sample of women living in Singapore. J Clin Aesthet Dermatol. 2016;9(1):21–24.
   PubMedGoogle Scholar
• Jusuf NK, Putra IB, Mahdalena M. Is there a correlation between severity of melasma and quality of life? Open Access Maced J Med Sci. 2019;7(16):2615–2618. doi:10.3889/oamjms.2019.407
   PubMedGoogle Scholar
• Anderson L, Rodrigues M. Quality of life in a cohort of melasma patients in Australia. Australas J Dermatol. 2019;60(2):160–162. doi:10.1111/ajd.12969
   PubMed Web of Science ®Google Scholar
• D’Elia MP, Brandão MC, de Andrade Ramos BR, et al. African ancestry is associated with facial melasma in women: a cross-sectional study. BMC Med Genet. 2017;18(1):17. doi:10.1186/s12881-017-0378-7
   PubMedGoogle Scholar
• Ogbechie-Godec OA, Elbuluk N. Melasma: an up-to-date comprehensive review. Dermatol Ther (Heidelb). 2017;7(3):305–318. doi:10.1007/s13555-017-0194-1
   PubMed Web of Science ®Google Scholar
• Espósito ACC, Cassiano DP, da Silva CN, et al. Update on melasma-part I: pathogenesis. Dermatol Ther (Heidelb). 2022;12(9):1967–1988. doi:10.1007/s13555-022-00779-x
   PubMed Web of Science ®Google Scholar
• Holmo NF, Ramos GB, Salomão H, et al. Complex segregation analysis of facial melasma in Brazil: evidence for a genetic susceptibility with a dominant pattern of segregation. Arch Dermatol Res. 2018;310(10):827–831. doi:10.1007/s00403-018-1861-5
   PubMed Web of Science ®Google Scholar
• Kang HY, Suzuki I, Lee DJ, et al. Transcriptional profiling shows altered expression of Wnt Pathway- and lipid metabolism-related genes as well as melanogenesis-related genes in melasma. J Invest Dermatol. 2011;131(8):1692–1700. doi:10.1038/jid.2011.109
   PubMed Web of Science ®Google Scholar
• Schaefer LV, Pontes LG, Cavassan NRV, Santos LDD, Miot HA. Proteomic study of facial melasma. An Bras Dermatol. 2022;97(6):808–814. doi:10.1016/j.abd.2021.06.010
   PubMed Web of Science ®Google Scholar
• Passeron T, Picardo M. Melasma, a photoaging disorder. Pigment Cell Melanoma Res. 2018;31(4):461–465. doi:10.1111/pcmr.12684
   PubMed Web of Science ®Google Scholar
• Yang J, Zeng J, Lu J. Mechanisms of ultraviolet-induced melasma formation: a review. J Dermatol. 2022;49(12):1201–1210. doi:10.1111/1346-8138.16542
   PubMed Web of Science ®Google Scholar
• Fatima S, Braunberger T, Mohammad TF, Kohli I, Hamzavi IH. The role of sunscreen in melasma and postinflammatory hyperpigmentation. Indian J Dermatol. 2020;65(1):5–10. doi:10.4103/ijd.IJD_295_18
   PubMed Web of Science ®Google Scholar
• Serre C, Busuttil V, Botto JM. Intrinsic and extrinsic regulation of human skin melanogenesis and pigmentation. Int J Cosmet Sci. 2018;40(4):328–347. doi:10.1111/ics.12466
   PubMed Web of Science ®Google Scholar
• Bernerd F, Marionnet C, Duval C. Solar ultraviolet radiation induces biological alterations in human skin in vitro: relevance of a well-balanced Uva/Uvb protection. Indian J Dermatol Venereol Leprol. 2012;78(Suppl 1):S15–S23. doi:10.4103/0378-6323.97351
   PubMedGoogle Scholar
• Han M, Ban JJ, Bae JS, Shin CY, Lee DH, Chung JH. UV irradiation to mouse skin decreases hippocampal neurogenesis and synaptic protein expression via Hpa axis activation. Sci Rep. 2017;7(1):15574. doi:10.1038/s41598-017-15773-z
   PubMedGoogle Scholar
• Kapoor R, Dhatwalia SK, Kumar R, Rani S, Parsad D. Emerging role of dermal compartment in skin pigmentation: comprehensive review. J Eur Acad Dermatol Venereol. 2020;34(12):2757–2765. doi:10.1111/jdv.16404
   PubMed Web of Science ®Google Scholar
• Regazzetti C, Sormani L, Debayle D, et al. Melanocytes sense blue light and regulate pigmentation through opsin-3. J Invest Dermatol. 2018;138(1):171–178. doi:10.1016/j.jid.2017.07.833
   PubMed Web of Science ®Google Scholar
• Espósito ACC, de Souza NP, Miot LDB, Miot HA. Expression of opn3 in fibroblasts, melanocytes, and keratinocytes of skin with facial melasma in comparison with unaffected adjacent skin. An Bras Dermatol. 2021;96(3):367–369. doi:10.1016/j.abd.2020.05.016
   PubMed Web of Science ®Google Scholar
• Narla S, Kohli I, Hamzavi IH, Lim HW. Visible light in photodermatology. Photochem Photobiol Sci. 2020;19(1):99–104. doi:10.1039/c9pp00425d
   PubMed Web of Science ®Google Scholar
• Duteil L, Cardot-Leccia N, Queille-Roussel C, et al. Differences in visible light-induced pigmentation according to wavelengths: a clinical and histological study in comparison with uvb exposure. Pigment Cell Melanoma Res. 2014;27(5):822–826. doi:10.1111/pcmr.12273
   PubMed Web of Science ®Google Scholar
• Duteil L, Queille-Roussel C, Lacour JP, Montaudié H, Passeron T. Short-term exposure to blue light emitted by electronic devices does not worsen melasma. J Am Acad Dermatol. 2020;83(3):913–914. doi:10.1016/j.jaad.2019.12.047
   PubMed Web of Science ®Google Scholar
• Ceresnie MS, Patel J, Lim HW, Kohli I. The cutaneous effects of blue light from electronic devices: a systematic review with health hazard identification. Photochem Photobiol Sci. 2022. doi:10.1007/s43630-022-00318-9
   PubMed Web of Science ®Google Scholar
• Boukari F, Jourdan E, Fontas E, et al. Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: a prospective randomized comparative trial. J Am Acad Dermatol. 2015;72(1):189–190.e1. doi:10.1016/j.jaad.2014.08.023
   PubMed Web of Science ®Google Scholar
• Handel AC, Lima PB, Tonolli VM, Miot LD, Miot HA. Risk factors for facial melasma in women: a case-control study. Br J Dermatol. 2014;171(3):588–594. doi:10.1111/bjd.13059
   PubMed Web of Science ®Google Scholar
• Locci-Molina N, Wang A, Kroumpouzos G. Melasma improving spontaneously upon switching from a combined oral contraceptive to a hormone-releasing intrauterine device: a report of four cases. Acta Derm Venereol. 2015;95(5):624–625. doi:10.2340/00015555-2013
   PubMed Web of Science ®Google Scholar
• Natale CA, Duperret EK, Zhang J, et al. Sex steroids regulate skin pigmentation through nonclassical membrane-bound receptors. Elife. 2016;5:e15104. doi:10.7554/eLife.15104
   PubMed Web of Science ®Google Scholar
• Goandal NF, Rungby J, Karmisholt KE. The role of sex hormones in the pathogenesis of melasma. Ugeskr Laeger. 2022;184(6):V10210769.
   PubMedGoogle Scholar
• Tamega Ade A, Miot HA, Moço NP, Silva MG, Marques ME, Miot LD. Gene and protein expression of oestrogen-β and progesterone receptors in facial melasma and adjacent healthy skin in women. Int J Cosmet Sci. 2015;37(2):222–228. doi:10.1111/ics.12186
   PubMed Web of Science ®Google Scholar
• Lee AY. Recent progress in melasma pathogenesis. Pigment Cell Melanoma Res. 2015;28(6):648–660. doi:10.1111/pcmr.12404
   PubMed Web of Science ®Google Scholar
• Cario M. How hormones may modulate human skin pigmentation in melasma: an in vitro perspective. Exp Dermatol. 2019;28(6):709–718. doi:10.1111/exd.13915
   PubMed Web of Science ®Google Scholar
• Filoni A, Mariano M, Cameli N. Melasma: how hormones can modulate skin pigmentation. J Cosmet Dermatol. 2019;18(2):458–463. doi:10.1111/jocd.12877
   PubMed Web of Science ®Google Scholar
• Kim NH, Lee CH, Lee AY. H19 RNA downregulation stimulated melanogenesis in melasma. Pigment Cell Melanoma Res. 2010;23(1):84–92. doi:10.1111/j.1755-148X.2009.00659.x
   PubMed Web of Science ®Google Scholar
• Spałkowska M, Dyduch G, Broniatowska E, Damiani G, Wojas-Pelc A. Molecular proof of a clinical concept: expression of estrogen alpha-, beta-receptors and G protein-coupled estrogen receptor 1 (Gper) in histologically assessed common nevi, dysplastic nevi and melanomas. Medicina. 2021;57(11):1228. doi:10.3390/medicina57111228
   PubMedGoogle Scholar
• Esposito ACC, Brianezi G, de Souza NP, Miot LDB, Marques MEA, Miot HA. Exploring pathways for sustained melanogenesis in facial melasma: an immunofluorescence study. Int J Cosmet Sci. 2018;40(4):420–424. doi:10.1111/ics.12468
   PubMed Web of Science ®Google Scholar
• Swope VB, Abdel-Malek ZA. Mc1r: front and center in the bright side of dark eumelanin and DNA repair. Int J Mol Sci. 2018;19(9):2667. doi:10.3390/ijms19092667
   PubMed Web of Science ®Google Scholar
• Gelmi MC, Houtzagers LE, Strub T, Krossa I, Jager MJ. Mitf in normal melanocytes, cutaneous and uveal melanoma: a delicate balance. Int J Mol Sci. 2022;23(11):6001. doi:10.3390/ijms23116001
   PubMed Web of Science ®Google Scholar
• Kim NH, Cheong KA, Lee TR, Lee AY. Pdzk1 upregulation in estrogen-related hyperpigmentation in melasma. J Invest Dermatol. 2012;132(11):2622–2631. doi:10.1038/jid.2012.175
   PubMed Web of Science ®Google Scholar
• Harno E, Gali Ramamoorthy T, Coll AP, White A. Pomc: the physiological power of hormone processing. Physiol Rev. 2018;98(4):2381–2430. doi:10.1152/physrev.00024.2017
   PubMed Web of Science ®Google Scholar
• Yardman-Frank JM, Fisher DE. Skin pigmentation and its control: from ultraviolet radiation to stem cells. Exp Dermatol. 2021;30(4):560–571. doi:10.1111/exd.14260
   PubMed Web of Science ®Google Scholar
• Sarkar R, Ailawadi P, Garg S. Melasma in men: a review of clinical, etiological, and management issues. J Clin Aesthet Dermatol. 2018;11(2):53–59.
   PubMedGoogle Scholar
• Brianezi G, Handel AC, Schmitt JV, Miot LD, Miot HA. Changes in nuclear morphology and chromatin texture of basal keratinocytes in melasma. J Eur Acad Dermatol Venereol. 2015;29(4):809–812. doi:10.1111/jdv.12453
   PubMed Web of Science ®Google Scholar
• Lentsch G, Balu M, Williams J, et al. In vivo multiphoton microscopy of melasma. Pigment Cell Melanoma Res. 2019;32(3):403–411. doi:10.1111/pcmr.12756
   PubMed Web of Science ®Google Scholar
• Espósito ACC, Brianezi G, de Souza NP, Miot LDB, Miot HA. Exploratory study of epidermis, basement membrane zone, upper dermis alterations and Wnt pathway activation in melasma compared to adjacent and retroauricular skin. Ann Dermatol. 2020;32(2):101–108. doi:10.5021/ad.2020.32.2.101
   PubMed Web of Science ®Google Scholar
• Yuan XH, Jin ZH. Paracrine regulation of melanogenesis. Br J Dermatol. 2018;178(3):632–639. doi:10.1111/bjd.15651
   PubMed Web of Science ®Google Scholar
• Wang Y, Viennet C, Robin S, Berthon JY, He L, Humbert P. Precise role of dermal fibroblasts on melanocyte pigmentation. J Dermatol Sci. 2017;88(2):159–166. doi:10.1016/j.jdermsci.2017.06.018
   PubMed Web of Science ®Google Scholar
• Xing X, Xu Z, Chen L, Jin S, Zhang C, Xiang L. Tranexamic acid inhibits melanogenesis partially via stimulation of TGF-beta1 expression in human epidermal keratinocytes. Exp Dermatol. 2022;31(4):633–640. doi:10.1111/exd.14509
   PubMed Web of Science ®Google Scholar
• Kwon SH, Hwang YJ, Lee SK, Park KC. Heterogeneous pathology of melasma and its clinical implications. Int J Mol Sci. 2016;17(6):824. doi:10.3390/ijms17060824
   PubMed Web of Science ®Google Scholar
• Esposito ACC, Brianezi G, de Souza NP, Santos DC, Miot LDB, Miot HA. Ultrastructural characterization of damage in the basement membrane of facial melasma. Arch Dermatol Res. 2020;312(3):223–227. doi:10.1007/s00403-019-01979-w
   PubMed Web of Science ®Google Scholar
• Gautam M, Patil S, Nadkarni N, Sandhu M, Godse K, Setia M. Histopathological comparison of lesional and perilesional skin in melasma: a cross-sectional analysis. Indian J Dermatol Venereol Leprol. 2019;85(4):367–373. doi:10.4103/ijdvl.IJDVL_866_17
   PubMed Web of Science ®Google Scholar
• Byun JW, Park IS, Choi GS, Shin J. Role of fibroblast-derived factors in the pathogenesis of melasma. Clin Exp Dermatol. 2016;41(6):601–609. doi:10.1111/ced.12874
   PubMed Web of Science ®Google Scholar
• Zhu JW, Ni YJ, Tong XY, Guo X, Wu XP. Activation of VEGF receptors in response to uvb promotes cell proliferation and melanogenesis of normal human melanocytes. Exp Cell Res. 2020;387(2):111798. doi:10.1016/j.yexcr.2019.111798
   PubMed Web of Science ®Google Scholar
• Trivedi MK, Yang FC, Cho BK. A review of laser and light therapy in melasma. Int J Womens Dermatol. 2017;3(1):11–20. doi:10.1016/j.ijwd.2017.01.004
   PubMedGoogle Scholar
• Regazzetti C, De Donatis GM, Ghorbel HH, et al. Endothelial cells promote pigmentation through endothelin receptor B activation. J Invest Dermatol. 2015;135(12):3096–3104. doi:10.1038/jid.2015.332
   PubMed Web of Science ®Google Scholar
• Niwano T, Terazawa S, Sato Y, Kato T, Nakajima H, Imokawa G. Glucosamine abrogates the stem cell factor + endothelin-1-induced stimulation of melanogenesis via a deficiency in mitf expression due to the proteolytic degradation of creb in human melanocytes. Arch Dermatol Res. 2018;310(8):625–637. doi:10.1007/s00403-018-1850-8
   PubMed Web of Science ®Google Scholar
• Lajis AFB, Ariff AB. Discovery of new depigmenting compounds and their efficacy to treat hyperpigmentation: evidence from in vitro study. J Cosmet Dermatol. 2019;18(3):703–727. doi:10.1111/jocd.12900
   PubMed Web of Science ®Google Scholar
• Samaka RM, Bakry OA, Shoeib MA, Zaaza MM. Expression of iNOS and NF-Kappab in melasma: an immunohistochemical study. Anal Quant Cytopathol Histpathol. 2014;36(5):245–257.
   PubMed Web of Science ®Google Scholar
• Atef A, El-Rashidy MA, Abdel Azeem A, Kabel AM. The role of stem cell factor in hyperpigmented skin lesions. Asian Pac J Cancer Prev. 2019;20(12):3723–3728. doi:10.31557/APJCP.2019.20.12.3723
   PubMedGoogle Scholar
• Kim JY, Lee TR, Lee AY. Reduced Wif-1 expression stimulates skin hyperpigmentation in patients with melasma. J Invest Dermatol. 2013;133(1):191–200. doi:10.1038/jid.2012.270
   PubMed Web of Science ®Google Scholar
• Kim M, Han JH, Kim JH, Park TJ, Kang HY. Secreted frizzled-related protein 2 (Sfrp2) functions as a melanogenic stimulator; the role of sfrp2 in UV-induced hyperpigmentary disorders. J Invest Dermatol. 2016;136(1):236–244. doi:10.1038/JID.2015.365
   PubMed Web of Science ®Google Scholar
• Eom YS, Jeong D, Ryu AR, Song KH, Im DS, Lee MY. Daphne odora exerts depigmenting effects via inhibiting Creb/Mitf and activating Akt/Erk-signaling pathways. Curr Issues Mol Biol. 2022;44(8):3312–3323. doi:10.3390/cimb44080228
   PubMed Web of Science ®Google Scholar
• Kim T, Hyun CG. Imperatorin positively regulates melanogenesis through signaling pathways involving Pka/ Creb, Erk, Akt, and Gsk3β/Β-catenin. Molecules. 2022;27(19):6512. doi:10.3390/molecules27196512
   PubMed Web of Science ®Google Scholar
• Yoon JH, Youn K, Jun M. Discovery of pinostrobin as a melanogenic agent in cAMP/PKA and p38 MAPK signaling pathway. Nutrients. 2022;14(18):3713. doi:10.3390/nu14183713
   PubMed Web of Science ®Google Scholar
• Kim NH, Choi SH, Kim CH, Lee CH, Lee TR, Lee AY. Reduced Mir-675 in exosome in H19 RNA-related melanogenesis via mitf as a direct target. J Invest Dermatol. 2014;134(4):1075–1082. doi:10.1038/jid.2013.478
   PubMed Web of Science ®Google Scholar
• Jin S, Chen L, Xu Z, Xing X, Zhang C, Xiang L. 585 Nm light-emitting diodes inhibit melanogenesis through upregulating H19/Mir-675 axis in LEDs-irradiated keratinocytes by paracrine effect. J Dermatol Sci. 2020;98(2):102–108. doi:10.1016/j.jdermsci.2020.03.002
   PubMed Web of Science ®Google Scholar
• Jung JM, Noh TK, Jo SY, et al. Guanine deaminase in human epidermal keratinocytes contributes to skin pigmentation. Molecules. 2020;25(11):2637. doi:10.3390/molecules25112637
   PubMed Web of Science ®Google Scholar
• Choubey V, Sarkar R, Garg V, Kaushik S, Ghunawat S, Sonthalia S. Role of oxidative stress in melasma: a prospective study on serum and blood markers of oxidative stress in melasma patients. Int J Dermatol. 2017;56(9):939–943. doi:10.1111/ijd.13695
   PubMed Web of Science ®Google Scholar
• Rahimi H, Mirnezami M, Yazdabadi A. Bilirubin as a new antioxidant in melasma. J Cosmet Dermatol. 2022;21(11):5800–5803. doi:10.1111/jocd.15240
   PubMed Web of Science ®Google Scholar
• Hexsel D, Lacerda DA, Cavalcante AS, et al. Epidemiology of melasma in Brazilian patients: a multicenter study. Int J Dermatol. 2014;53(4):440–444. doi:10.1111/j.1365-4632.2012.05748.x
   PubMed Web of Science ®Google Scholar
• Adalatkhah H, Sadeghi Bazargani H. The Association between melasma and postin flammatory hyperpigmentation in acne patients. Iran Red Crescent ME. 2013;15(5):400–403. doi:10.5812/ircmj.5358
   PubMed Web of Science ®Google Scholar
• Liu C, He D, Yu A, Deng Y, Wang L, Song Z. Correlation analysis between gut microbiota characteristics and melasma. Front Microbiol. 2022;13:1051653. doi:10.3389/fmicb.2022.1051653
   PubMed Web of Science ®Google Scholar
• Katoh M, Katoh M. Molecular genetics and targeted therapy of wnt-related human diseases (review). Int J Mol Med. 2017;40(3):587–606. doi:10.3892/ijmm.2017.3071
   PubMed Web of Science ®Google Scholar
• Imokawa G, Ishida K. Inhibitors of intracellular signaling pathways that lead to stimulated epidermal pigmentation: perspective of anti-pigmenting agents. Int J Mol Sci. 2014;15(5):8293–8315. doi:10.3390/ijms15058293
   PubMed Web of Science ®Google Scholar
• Zhou S, Sakamoto K. Pyruvic acid/ethyl pyruvate inhibits melanogenesis in b16f10 melanoma cells through Pi3k/Akt, Gsk3beta, and Ros-Erk signaling pathways. Genes Cells. 2019;24(1):60–69. doi:10.1111/gtc.12654
   PubMed Web of Science ®Google Scholar
• Hossain MR, Ansary TM, Komine M, Ohtsuki M. Diversified stimuli-induced inflammatory pathways cause skin pigmentation. Int J Mol Sci. 2021;22(8):3970. doi:10.3390/ijms22083970
   PubMed Web of Science ®Google Scholar
• Fang J, Ouyang M, Qu Y, et al. Advanced glycation end products promote melanogenesis by activating NLRP3 inflammasome in human dermal fibroblasts. J Invest Dermatol. 2022;142(10):2591–2602.e8. doi:10.1016/j.jid.2022.03.025
   PubMed Web of Science ®Google Scholar
• Khunger N, Kandhari R, Singh A, Ramesh V. A clinical, dermoscopic, histopathological and immunohistochemical study of melasma and facial pigmentary demarcation lines in the skin of color. Dermatol Ther. 2020;33(6):e14515. doi:10.1111/dth.14515
   PubMed Web of Science ®Google Scholar
• Kovács D, Fazekas F, Oláh A, Törőcsik D. Adipokines in the Skin and in Dermatological Diseases. Int J Mol Sci. 2020;21(23):9048. doi:10.3390/ijms21239048
   PubMed Web of Science ®Google Scholar
• Flori E, Mastrofrancesco A, Mosca S, et al. Sebocytes contribute to melasma onset. iScience. 2022;25(3):103871. doi:10.1016/j.isci.2022.103871
   PubMed Web of Science ®Google Scholar